CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Online support GroupWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D012598 Scoliosi NIH 0.35
D009103 Multiple Sclerosis NIH 0.33

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 SUNLIGHT Study: Online Support Groups for Multiple Sclerosis (MS) to Address COVID-19

Stress and anxiety can have an adverse impact on health, and the experience of many around the 2020 outbreak of COVID-19 is affecting health and well-being. Individuals with chronic disease such as multiple sclerosis may be particularly vulnerable in some ways, but also particularly resilient in others. This study evaluates the effects of belonging to online support groups that meet weekly for 12 weeks to address the stress and anxiety felt by individuals with Multiple Sclerosis (MS). This study will also measure and explore the effects of online support groups.

NCT04379661 MS (Multiple Sclerosis) COVID-19 Support Groups Behavioral: Online support Group
MeSH:Multiple Sclerosis Sclerosis

Primary Outcomes

Description: Acceptable rate is defined as at least 66% of participants who complete follow-up surveys.

Measure: Rate of completion

Time: Up to 12 weeks

Description: Acceptable rate is defined as at least 66% of sessions being attended.

Measure: Rate of adherence

Time: Up to 12 weeks

Secondary Outcomes

Description: The STAI is a commonly used measure of trait and state anxiety that is scored from 20 (minimum score) to 80 (maximum score), with a higher scores indicating higher anxiety (worse outcome).

Measure: Score on the State Trait Anxiety Inventory (STAI)

Time: Up to 12 weeks

Description: Mood as measured by change in depression or depressive symptoms will be measured with the 8-item PHQ-8 which is scored from 0 (minimum score) to 24 (maximum score), in which higher scores indicate higher depression or depressive symptoms (worse outcome).

Measure: Score on the Personal Health Questionnaire Depression Scale (PHQ-8)

Time: Up to 12 weeks

No related HPO nodes (Using clinical trials)